2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American …

MD Gerhard-Herman, HL Gornik, C Barrett… - Journal of the American …, 2017 - jacc.org
The recommendations listed in this guideline are, whenever possible, evidence based. An
initial extensive evidence review, which included literature derived from research involving …

An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the Inter-Society …

TASC Steering Committee*, MR Jaff… - Journal of …, 2015 - journals.sagepub.com
The Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC)
guidelines were last updated in 2007 (TASC II) and represented the collaboration of …

[HTML][HTML] Global vascular guidelines on the management of chronic limb-threatening ischemia

MS Conte, AW Bradbury, P Kolh, JV White… - European Journal of …, 2019 - Elsevier
Guideline Summary Chronic limb-threatening ischemia (CLTI) is associated with mortality,
amputation, and impaired quality of life. These Global Vascular Guidelines (GVG) are …

[HTML][HTML] ESVM Guideline on peripheral arterial disease

U Frank, S Nikol, J Belch, V Boc, M Brodmann… - Vasa, 2019 - econtent.hogrefe.com
The European Society of Vascular Medicine (ESVM) was founded in Paris in 2012 as a
confederation of already existing and emerging European societies of vascular medicine. At …

Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence

H Reinecke, M Unrath, E Freisinger… - European heart …, 2015 - academic.oup.com
Aims Only few and historic studies reported a bad prognosis of peripheral arterial disease
(PAD) and critical limb ischaemia (CLI). The contemporary state of treatment and outcomes …

Risk of death and amputation with use of paclitaxel-coated balloons in the infrapopliteal arteries for treatment of critical limb ischemia: a systematic review and meta …

K Katsanos, S Spiliopoulos, P Kitrou, M Krokidis… - Journal of Vascular and …, 2020 - Elsevier
A formal systematic review and study-level meta-analysis of randomized controlled trials
investigating treatment of the infrapopliteal arteries with paclitaxel-coated balloons …

Calcium burden assessment and impact on drug-eluting balloons in peripheral arterial disease

F Fanelli, A Cannavale, M Gazzetti, P Lucatelli… - Cardiovascular and …, 2014 - Springer
Purpose This study was designed to assess the effect of calcium on the efficacy of DEB
during revascularization of steno-obstructive SFA lesions. Methods Sixty patients with de …

Endovascular intervention for peripheral artery disease

AK Thukkani, S Kinlay - Circulation research, 2015 - Am Heart Assoc
Advances in endovascular therapies during the past decade have broadened the options for
treating peripheral vascular disease percutaneously. Endovascular treatment offers a lower …

Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN. PACT …

T Zeller, I Baumgartner, D Scheinert… - Journal of the American …, 2014 - jacc.org
Background: Drug-eluting balloons (DEB) may reduce infrapopliteal restenosis and
reintervention rates versus percutaneous transluminal angioplasty (PTA) and improve …

Peripheral artery disease: evolving role of exercise, medical therapy, and endovascular options

JW Olin, CJ White, EJ Armstrong… - Journal of the American …, 2016 - jacc.org
The prevalence of peripheral artery disease (PAD) continues to increase worldwide. It is
important to identify patients with PAD because of the increased risk of myocardial infarction …